# The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

> **NCT00673075** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 39 (actual)

## Conditions studied

- Hypertension
- Coronary Artery Disease

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT00673075
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-09
- **Final completion:** —
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2010-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673075, "The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00673075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*